TickerFactsScreenerDevelopers

Gossamer Bio, Inc. (GOSS) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2018: $105.22M2019: $135.03M2020: $486.06M2021: $183.40M2022: $111.97M2023: $32.11M2024: $46.07M2025: $37.73M$37.73M
2018Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$37.73M-18.1%
2024$46.07M+43.5%
2023$32.11M-71.3%
2022$111.97M-38.9%
2021$183.40M-62.3%
2020$486.06M+260.0%
2019$135.03M+28.3%
2018$105.22M—